John Peck
Director/Board Member at Batu Biologics, Inc.
Net worth: 227 283 $ as of 30/04/2024
Profile
John Peck is currently a Director at Batu Biologics, Inc. He holds an MBA from DePaul University and an undergraduate degree from Northern Illinois University, which he received in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2023 | 227,283,333 ( 5.37% ) | 227 283 $ | 30/04/2024 |
John Peck active positions
| Companies | Position | Start |
|---|---|---|
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Director/Board Member | 24/02/2017 |
Training of John Peck
| Northern Illinois University | Undergraduate Degree |
| DePaul University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Batu Biologics, Inc.
Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- John Peck
